1. Home
  2. FGBI vs HUMA Comparison

FGBI vs HUMA Comparison

Compare FGBI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Guaranty Bancshares Inc.

FGBI

First Guaranty Bancshares Inc.

HOLD

Current Price

$10.00

Market Cap

151.6M

Sector

Finance

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.30

Market Cap

155.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FGBI
HUMA
Founded
1934
2004
Country
United States
United States
Employees
346
184
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.6M
155.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FGBI
HUMA
Price
$10.00
$1.30
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$6.19
AVG Volume (30 Days)
34.4K
6.7M
Earning Date
04-27-2026
05-15-2026
Dividend Yield
0.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$567.70
$444.16
Revenue Next Year
N/A
$248.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.31
$0.55
52 Week High
$10.36
$2.93

Technical Indicators

Market Signals
Indicator
FGBI
HUMA
Relative Strength Index (RSI) 54.00 68.49
Support Level $9.32 $0.89
Resistance Level $10.03 $1.72
Average True Range (ATR) 0.41 0.13
MACD 0.09 0.03
Stochastic Oscillator 52.24 92.45

Price Performance

Historical Comparison
FGBI
HUMA

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: